An IgG‐based bispecific antibody for improved dual targeting in PSMA‐positive cancer

Abstract The prostate‐specific membrane antigen (PSMA) has been demonstrated in numerous studies to be expressed specifically on prostate carcinoma cells and on the neovasculature of several other cancer entities. However, the simultaneous expression of PSMA on both, tumor cells as well as tumor ves...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Latifa Zekri, Fabian Vogt, Lukas Osburg, Stefanie Müller, Joseph Kauer, Timo Manz, Martin Pflügler, Andreas Maurer, Jonas S Heitmann, Ilona Hagelstein, Melanie Märklin, Sebastian Hörner, Tilmann Todenhöfer, Carsten Calaminus, Arnulf Stenzl, Bernd Pichler, Christian la Fougère, Marc A Schneider, Hans‐Georg Rammensee, Lars Zender, Bence Sipos, Helmut R Salih, Gundram Jung
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Springer Nature 2020-12-01
סדרה:	EMBO Molecular Medicine
נושאים:	bispecific antibody immunotherapy lung cancer prostate cancer PSMA
גישה מקוונת:	https://doi.org/10.15252/emmm.201911902
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!